Acute Myeloid Leukemia Response Measures Other Than Complete Remission
Donna Przepiorka1, Albert Deisseroth2, Ann T Farrell2
1US Food and Drug Administration, Silver Spring, MD donna.przepiorka@fda.hhs.gov.
Abstract
No abstract available in PubMed .
More Related Videos
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
849
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.9K
